ArticleCell death & disease2026

HIF1 inhibition targets tumoral and myeloid cells, and is a promising therapy for metastatic castration-resistant prostate cancer.

Darya Yanushko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.